irsogladine has been researched along with Chronic Disease in 1 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| " To investigate the therapeutic approach to intestinal fibrosis, we have developed a mouse model of intestinal fibrosis by administering dextran sulfate sodium (DSS) and examining the effects of irsogladine maleate (IM) [2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate], which has been widely used as an antiulcer drug for gastric mucosa in Japan, on DDS-induced chronic colitis." | 7.78 | Irsogladine maleate ameliorates inflammation and fibrosis in mice with chronic colitis induced by dextran sulfate sodium. ( Asakura, H; Kawachi, H; Kawase, T; Kawauchi, Y; Nagata, M; Sukumaran, V; Suzuki, K; Takagi, R; Thandavarayan, RA; Tomita, M; Watanabe, K; Yamaguchi, H; Yokoyama, J; Yoneyama, H, 2012) |
| " To investigate the therapeutic approach to intestinal fibrosis, we have developed a mouse model of intestinal fibrosis by administering dextran sulfate sodium (DSS) and examining the effects of irsogladine maleate (IM) [2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate], which has been widely used as an antiulcer drug for gastric mucosa in Japan, on DDS-induced chronic colitis." | 3.78 | Irsogladine maleate ameliorates inflammation and fibrosis in mice with chronic colitis induced by dextran sulfate sodium. ( Asakura, H; Kawachi, H; Kawase, T; Kawauchi, Y; Nagata, M; Sukumaran, V; Suzuki, K; Takagi, R; Thandavarayan, RA; Tomita, M; Watanabe, K; Yamaguchi, H; Yokoyama, J; Yoneyama, H, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamaguchi, H | 1 |
| Suzuki, K | 1 |
| Nagata, M | 1 |
| Kawase, T | 1 |
| Sukumaran, V | 1 |
| Thandavarayan, RA | 1 |
| Kawauchi, Y | 1 |
| Yokoyama, J | 1 |
| Tomita, M | 1 |
| Kawachi, H | 1 |
| Watanabe, K | 1 |
| Yoneyama, H | 1 |
| Asakura, H | 1 |
| Takagi, R | 1 |
1 other study available for irsogladine and Chronic Disease
| Article | Year |
|---|---|
Irsogladine maleate ameliorates inflammation and fibrosis in mice with chronic colitis induced by dextran sulfate sodium.
Topics: Animals; Anti-Ulcer Agents; Chronic Disease; Colitis; Dextran Sulfate; Disease Models, Animal; Femal | 2012 |